The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.
Kent S. et al, (2019), PharmacoEconomics
Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients.
Tew M. et al, (2019), Pharmacoeconomics, 37, 931 - 941
Transparency in Decision Modelling: What, Why, Who and How?
Sampson CJ. et al, (2019), Pharmacoeconomics
The impact of Medicare part D on income-related inequality in pharmaceutical expenditure
Carvalho N. et al, (2019), International Journal for Equity in Health, 18
Development and Use of Prediction Models for Classification of Cardiovascular Risk of Remote Indigenous Australians.
Tran-Duy A. et al, (2019), Heart, lung & circulation
Excess burden of mental illness and hospitalization in young-onset type 2 diabetes: A population-based cohort study
Ke C. et al, (2019), Annals of Internal Medicine, 170, 145 - 154
Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
Blakely T. et al, (2019), PLoS Med, 16
Modelling the impact of multiple sclerosis on life expectancy, quality-adjusted life years and total lifetime costs: Evidence from Australia
Palmer AJ. et al, (2019), Multiple Sclerosis Journal
Accuracy of patient recall for self-reported doctor visits: Is shorter recall better?
Dalziel K. et al, (2018), Health Econ, 27, 1684 - 1698
An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity: Results From a Pragmatic Open-Label Trial
Tran-Duy A. et al, (2018), Arthritis and Rheumatology, 70, 1557 - 1564
Life satisfaction, QALYs, and the monetary value of health.
Huang L. et al, (2018), Soc Sci Med, 211, 131 - 136
Born equal? The distribution of government Medicare spending for children.
Dalziel KM. et al, (2018), Soc Sci Med, 208, 50 - 54
Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.
McAuley SA. et al, (2018), BMJ Open, 8
Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis.
Lim LL. et al, (2018), Diabetes Care, 41, 1312 - 1320
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.
Palmer AJ. et al, (2018), Value Health, 21, 724 - 731
Longevity of outstanding sporting achievers: Mind versus muscle.
Tran-Duy A. et al, (2018), PLoS One, 13
Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort.
Hua X. et al, (2017), Eur J Prev Cardiol, 24, 1660 - 1669
Using Patient-Reported Outcomes for Economic Evaluation: Getting the Timing Right.
Schilling C. et al, (2016), Value Health, 19, 945 - 950
Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report.
Wolowacz SE. et al, (2016), Value Health, 19, 704 - 719